We just received data on a new analyst forecast for $EMR. Julian Mitchell from Barclays set a price target of 125.0 for EMR.
To track analyst ratings and price targets for $EMR, check out Quiver Quantitative's $EMR forecast page.
$EMR Price Targets
Multiple analysts have issued price targets for $EMR recently. We have seen 9 analysts offer price targets for $EMR in the last 6 months, with a median target of $133.0.
Here are some recent targets:
- Julian Mitchell from Barclays set a target price of $125.0 on 07/09/2025
- Andrew Obin from B of A Securities set a target price of $155.0 on 07/02/2025
- Ken Newman from Keybanc set a target price of $155.0 on 07/01/2025
- Joseph O'Dea from Wells Fargo set a target price of $150.0 on 07/01/2025
- Andrew Kaplowitz from Citigroup set a target price of $146.0 on 06/04/2025
- Stephen Tusa from JP Morgan set a target price of $133.0 on 05/16/2025
- Michael Halloran from Baird set a target price of $130.0 on 05/08/2025
$EMR Congressional Stock Trading
Members of Congress have traded $EMR stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $EMR stock by members of Congress over the last 6 months:
- REPRESENTATIVE BRUCE WESTERMAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 03/03 and 1 sale worth up to $15,000 on 04/21.
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$EMR Insider Trading Activity
$EMR insiders have traded $EMR stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $EMR stock by insiders over the last 6 months:
- MICHAEL H. TRAIN (SVP & Chief Sustain Officer) sold 28,305 shares for an estimated $3,380,749
- SURENDRALAL LANCA KARSANBHAI (President & CEO) sold 16,698 shares for an estimated $1,892,384
- MARK A BLINN has made 0 purchases and 2 sales selling 1,887 shares for an estimated $237,205.
- MATTHEW S LEVATICH sold 1,867 shares for an estimated $233,472
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EMR Hedge Fund Activity
We have seen 843 institutional investors add shares of $EMR stock to their portfolio, and 952 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 2,164,069 shares (+71.6%) to their portfolio in Q1 2025, for an estimated $237,268,525
- PACER ADVISORS, INC. added 2,138,397 shares (+4583.7%) to their portfolio in Q1 2025, for an estimated $234,453,847
- VAN ECK ASSOCIATES CORP removed 1,960,317 shares (-97.6%) from their portfolio in Q1 2025, for an estimated $214,929,155
- ALLIANCEBERNSTEIN L.P. added 1,693,999 shares (+218.7%) to their portfolio in Q1 2025, for an estimated $185,730,050
- FISHER ASSET MANAGEMENT, LLC added 1,595,914 shares (+78.4%) to their portfolio in Q1 2025, for an estimated $174,976,010
- BLACKROCK, INC. added 1,555,156 shares (+4.3%) to their portfolio in Q1 2025, for an estimated $170,507,303
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ added 1,333,839 shares (+210.8%) to their portfolio in Q1 2025, for an estimated $146,242,107
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
